Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders??? Equity (Deficit)

v3.22.2.2
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Deficit) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated other comprehensive income (loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2020   266,619,585      
Beginning balance at Dec. 31, 2020 $ (199,622) $ 27 $ 463,380 $ 134 $ (663,163)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (32,325)       (32,325)
Stock-based compensation 1,421   1,421    
Exercise of stock options (in shares)   2,789      
Exercise of stock options 21   21    
Advances to stock option holders 18   18    
Other comprehensive income (33)     (33)  
Issuance of common stock due to Parent Company contributions (in shares)   12,646,392      
Issuance of common stock due to Parent Company contributions 46,141 $ 1 46,140    
Conversion of long-term debt due to Parent Company to Parent Company non-cash contributions 235,108   235,108    
Ending balance (in shares) at Mar. 31, 2021   279,268,766      
Ending balance at Mar. 31, 2021 50,729 $ 28 746,088 101 (695,488)
Beginning balance (in shares) at Dec. 31, 2020   266,619,585      
Beginning balance at Dec. 31, 2020 (199,622) $ 27 463,380 134 (663,163)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (115,563)        
Ending balance (in shares) at Sep. 30, 2021   298,560,017      
Ending balance at Sep. 30, 2021 67,021 $ 30 845,685 32 (778,726)
Beginning balance (in shares) at Mar. 31, 2021   279,268,766      
Beginning balance at Mar. 31, 2021 50,729 $ 28 746,088 101 (695,488)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (44,648)       (44,648)
Stock-based compensation 1,327   1,327    
Exercise of stock options (in shares)   195,594      
Exercise of stock options 758   758    
Advances to stock option holders 0        
Other comprehensive income 13     13  
Issuance of common stock due to Parent Company contributions (in shares)   9,030,759      
Issuance of common stock due to Parent Company contributions 39,798 $ 1 39,797    
Ending balance (in shares) at Jun. 30, 2021   288,495,119      
Ending balance at Jun. 30, 2021 47,977 $ 29 787,970 114 (740,136)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (38,590)       (38,590)
Stock-based compensation 5,560   5,560    
Exercise of stock options (in shares)   245,190      
Exercise of stock options 954   954    
Advances to stock option holders 0        
Other comprehensive income (82)     (82)  
Issuance of common stock due to Parent Company contributions (in shares)   9,819,708      
Issuance of common stock due to Parent Company contributions 51,202 $ 1 51,201    
Reverse recapitalization, net of transaction costs (in shares)   0      
Reverse recapitalization, net of transaction costs 0 $ 0 0 0  
Ending balance (in shares) at Sep. 30, 2021   298,560,017      
Ending balance at Sep. 30, 2021 67,021 $ 30 845,685 32 (778,726)
Beginning balance (in shares) at Dec. 31, 2021   334,919,914      
Beginning balance at Dec. 31, 2021 212,970 $ 34 1,033,393 (3) (820,454)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (62,570)       (62,570)
Stock-based compensation 3,814   3,814    
Other comprehensive income (61)     (61)  
Ending balance (in shares) at Mar. 31, 2022   334,919,914      
Ending balance at Mar. 31, 2022 154,153 $ 34 1,037,207 (64) (883,024)
Beginning balance (in shares) at Dec. 31, 2021   334,919,914      
Beginning balance at Dec. 31, 2021 212,970 $ 34 1,033,393 (3) (820,454)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (139,505)        
Ending balance (in shares) at Sep. 30, 2022   336,145,621      
Ending balance at Sep. 30, 2022 89,487 $ 36 1,049,533 (123) (959,959)
Beginning balance (in shares) at Mar. 31, 2022   334,919,914      
Beginning balance at Mar. 31, 2022 154,153 $ 34 1,037,207 (64) (883,024)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (33,292)       (33,292)
Stock-based compensation 2,633   2,633    
Exercise of stock options (in shares)   182,609      
Exercise of stock options 651 $ 2 649    
Other comprehensive income (28)     (28)  
Ending balance (in shares) at Jun. 30, 2022   335,102,523      
Ending balance at Jun. 30, 2022 124,117 $ 36 1,040,489 (92) (916,316)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (43,643)       (43,643)
Stock-based compensation 5,508   5,508    
Exercise of stock options (in shares)   211,742      
Exercise of stock options $ 803   803    
Issuance of common stock due to Convertible Note conversion (in shares) 831,356,000 831,356      
Issuance of common stock due to Convertible Note conversion $ 2,733   2,733    
Other comprehensive income (31)     (31)  
Ending balance (in shares) at Sep. 30, 2022   336,145,621      
Ending balance at Sep. 30, 2022 $ 89,487 $ 36 $ 1,049,533 $ (123) $ (959,959)